文献速递甲状腺核医学核素与放射性配体治疗

123I闪烁显像显示毒性腺瘤放射性碘治疗后诱发的Graves病镜像表现

123I Scintigraphy Mirror Image of Graves Disease Induced by Radioiodine Treatment for Toxic Adenoma.
PubMed 文献 · Clin Nucl Med · 2022-01-01

61岁女性因毒性腺瘤接受131I治疗,6个月后甲亢复发,123I闪烁显像显示与首次显像呈镜像表现:原治疗结节外甲状腺弥漫性高摄取,促甲状腺素受体抗体升高确诊Graves病,第二次放射性碘治疗治愈。放射性碘诱发的Graves病可在毒性腺瘤131I治疗后6个月内发生,并可用第二程131I治疗。

要点

  • 毒性腺瘤131I治疗后6个月内可出现放射性碘诱发的Graves病。
  • 123I闪烁显像可显示与原毒性腺瘤镜像的甲状腺弥漫性高摄取。
  • 促甲状腺素受体抗体升高可确诊Graves病,第二程131I治疗可治愈。

核心结论

  • 放射性碘诱发的Graves病可在毒性腺瘤131I治疗后6个月内发生,并可用第二程131I治疗治愈。

研究设计与样本

  • 单例病例报告:61岁女性,因123I闪烁显像诊断的毒性腺瘤接受131I治疗。

主要发现

  • 131I治疗后6个月甲亢复发,123I闪烁显像显示原治疗结节外甲状腺弥漫性高摄取,与首次显像呈镜像表现。
  • 促甲状腺素受体抗体升高确诊Graves病,患者经第二次放射性碘治疗治愈。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 61-year-old woman presenting with hyperthyroidism received 131I therapy for a toxic adenoma diagnosed by 123I scintigraphy. Six months later, the patient had a relapse of hyperthyroidism, and 123I scintigraphy showed a mirror image of the first scintigraphy: a high and diffuse uptake in the thyroid gland except for the previously treated nodule. Graves disease was confirmed by elevated thyrotropin receptor antibodies. The patient was cured by a second radioiodine therapy. Radioiodine-induced Graves disease may occur within 6 months of 131I treatment of toxic adenoma and can be treated with a second line of 131I.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Lugat A, Drui D, Bach-Ngohou K, et al. 123I Scintigraphy Mirror Image of Graves Disease Induced by Radioiodine Treatment for Toxic Adenoma. Clin Nucl Med. 2022. PMID: 35006119. doi:10.1097/RLU.0000000000003884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。